{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,6]],"date-time":"2026-06-06T14:16:12Z","timestamp":1780755372407,"version":"3.54.1"},"reference-count":167,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,7,17]],"date-time":"2025-07-17T00:00:00Z","timestamp":1752710400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,7,17]],"date-time":"2025-07-17T00:00:00Z","timestamp":1752710400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Biol Rep"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1007\/s11033-025-10827-2","type":"journal-article","created":{"date-parts":[[2025,7,17]],"date-time":"2025-07-17T17:19:42Z","timestamp":1752772782000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Detection of anti-HCV antibodies in the clinical classification and epidemiological surveillance of HCV infection"],"prefix":"10.1007","volume":"52","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8909-9091","authenticated-orcid":false,"given":"Rob\u00e9rio Amorim de Almeida","family":"Pond\u00e9","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,17]]},"reference":[{"key":"10827_CR1","unstructured":"World Health Organizatio n (2022) WHO Publishes Updated Guidance on Hepatitis C Infection\u2014With New Recommendations on Treatment of Adolescents and Children, Simplified Service Delivery and Diagnostics. Available online: https:\/\/www.who.int\/news\/item\/24-06-2022-WHO-publishes-updated-guidance-on-hepatitis-C-infection (accessed on 24 February 2025)"},{"key":"10827_CR2","unstructured":"World Heath Organization (2024) Global Hepatitis Report 2024 Viral hepatitis B and C policies in countries and burden of disease in WHO regions. Available from https:\/\/cdn.who.int\/media\/docs\/default-source\/hq-hiv-hepatitis-and-stis-library\/hepatitis-factsheet_2023.pdf?sfvrsn=fd9e78cf_5 Accessed February 24, 2025"},{"key":"10827_CR3","unstructured":"World Heath Organization (2022) Updated Reccomendations on Simplified service delivery and diagnostics for hepatitis c infection; Available from: https:\/\/www.who.int\/publications\/i\/item\/9789240052697. Accessed February 18, 2025"},{"key":"10827_CR4","doi-asserted-by":"publisher","first-page":"102255","DOI":"10.1016\/j.tmaid.2022.10225","volume":"46","author":"N Salari","year":"2022","unstructured":"Salari N, Kazeminia M, Hemati N, Ammari-Allahyari M, Mohammadi M, Shohaimi S (2022) Global prevalence of hepatitis C in general population: A systematic review and meta-analysis. Travel Med Infect Dis 46:102255. https:\/\/doi.org\/10.1016\/j.tmaid.2022.10225","journal-title":"Travel Med Infect Dis"},{"key":"10827_CR5","unstructured":"WHO Hepatitis C\u2014Fact Sheets (2024) [(accessed on 24 February 2025)]. Available online: https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/hepatitis-c"},{"key":"10827_CR6","first-page":"1","volume-title":"Global health sector strategy on viral hepatitis 2016\u20132021","author":"World Health Organization","year":"2026","unstructured":"World Health Organization (2026) Global health sector strategy on viral hepatitis 2016\u20132021. WHO Document and Production Services, Geneva, pp 1\u201356"},{"key":"10827_CR7","doi-asserted-by":"crossref","unstructured":"Buckley GJ, Strom BL (2017) Committee on a National Strategy for the Elimination of Hepatitis B and C; Board on Population Health and Public Health Practice; Health and Medicine Division; National Academies of Sciences, Engineering, and Medicine, eds. A National Strategy for the Elimination of Hepatitis B and C: Phase Two Report. National Academies Press","DOI":"10.17226\/24731"},{"key":"10827_CR8","doi-asserted-by":"publisher","unstructured":"Stasi C, Milli C, Voller F (2024) The epidemiology of chronic hepatitis C: where we are now livers 4, no. 2172\u2013181. https:\/\/doi.org\/10.3390\/livers4020013. Caterina Silvestri","DOI":"10.3390\/livers4020013"},{"issue":"6","key":"10827_CR9","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1089\/jwh.2023.1114","volume":"33","author":"L Panagiotakopoulos","year":"2024","unstructured":"Panagiotakopoulos L, Miele K, Cartwright EJ, Kamili S, Furukawa N, Woodworth K, Tong VT, Kim SY, Wester C, Sandul AL (2024) CDC\u2019s new hepatitis C virus testing recommendations for perinatally exposed infants and children: A step towards hepatitis C elimination. J Womens Health (Larchmt) 33(6):695\u2013701. https:\/\/doi.org\/10.1089\/jwh.2023.1114","journal-title":"J Womens Health (Larchmt)"},{"issue":"7","key":"10827_CR10","doi-asserted-by":"publisher","first-page":"584","DOI":"10.2174\/1389557517666170913111930","volume":"18","author":"D Das","year":"2018","unstructured":"Das D, Pandya M (2018) Recent advancement of Direct-acting antiviral agents (DAAs) in hepatitis C therapy. Mini Rev Med Chem 18(7):584\u2013596. https:\/\/doi.org\/10.2174\/1389557517666170913111930","journal-title":"Mini Rev Med Chem"},{"issue":"8","key":"10827_CR11","doi-asserted-by":"publisher","first-page":"e43924","DOI":"10.7759\/cureus.43924","volume":"15","author":"LA Bernal","year":"2023","unstructured":"Bernal LA, Soti V (2023) Hepatitis C virus: insights into its history, treatment, challenges, and future directions. Cureus 15(8):e43924. https:\/\/doi.org\/10.7759\/cureus.43924","journal-title":"Cureus"},{"issue":"4","key":"10827_CR12","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1016\/j.bpg.2012.09.009","volume":"26","author":"B Maasoumy","year":"2012","unstructured":"Maasoumy B, Wedemeyer H (2012) Natural history of acute and chronic hepatitis C. Best Pract Res Clin Gastroenterol 26(4):401\u2013412. https:\/\/doi.org\/10.1016\/j.bpg.2012.09.009","journal-title":"Best Pract Res Clin Gastroenterol"},{"issue":"6","key":"10827_CR13","first-page":"626","volume":"104","author":"DL Maness","year":"2021","unstructured":"Maness DL, Riley E, Studebaker G (2021) Hepatitis C: diagnosis and management. Am Fam Physician 104(6):626\u2013635 PMID: 34913652","journal-title":"Am Fam Physician"},{"issue":"3","key":"10827_CR14","doi-asserted-by":"publisher","first-page":"623","DOI":"10.3350\/cmh.2022.0349","volume":"29","author":"CH Liu","year":"2023","unstructured":"Liu CH, Kao JH (2023) Acute hepatitis C virus infection: clinical update and remaining challenges. Clin Mol Hepatol 29(3):623\u2013642. https:\/\/doi.org\/10.3350\/cmh.2022.0349","journal-title":"Clin Mol Hepatol"},{"issue":"1","key":"10827_CR15","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1007\/s00430-010-0159-9","volume":"200","author":"RA Pond\u00e9","year":"2011","unstructured":"Pond\u00e9 RA (2011) Hidden hazards of HCV transmission. Med Microbiol Immunol 200(1):7\u201311. https:\/\/doi.org\/10.1007\/s00430-010-0159-9","journal-title":"Med Microbiol Immunol"},{"issue":"3","key":"10827_CR16","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1177\/0391398817752326","volume":"41","author":"N Papadopoulos","year":"2018","unstructured":"Papadopoulos N, Griveas I, Sveroni E, Argiana V, Kalliaropoulos A, Martinez-Gonzalez B, Deutsch M (2018) HCV viraemia in anti-HCV-negative haemodialysis patients: do we need HCV RNA detection test? Int J Artif Organs 41(3):168\u2013170. https:\/\/doi.org\/10.1177\/0391398817752326","journal-title":"Int J Artif Organs"},{"key":"10827_CR17","unstructured":"Maness DL, Riley E, Studebaker G (2021) Hepatitis C: Diagnosis and Management. Am Fam Physician. 1;104(6):626\u2013635"},{"key":"10827_CR18","doi-asserted-by":"publisher","unstructured":"Austria A, Wu GY (2018) Occult Hepatitis C Virus Infection: A Review. J Clin Transl Hepatol. 28;6(2):155\u2013160. https:\/\/doi.org\/10.14218\/JCTH.2017.00053","DOI":"10.14218\/JCTH.2017.00053"},{"issue":"2","key":"10827_CR19","doi-asserted-by":"publisher","first-page":"1","DOI":"10.15585\/mmwr.rr6902a1","volume":"10","author":"S Schillie","year":"2020","unstructured":"Schillie S, Wester C, Osborne M, Wesolowski L, Ryerson AB (2020) CDC recommendations for hepatitis C screening among Adults - United states, 2020. MMWR Recomm Rep 10(2):1\u201317. https:\/\/doi.org\/10.15585\/mmwr.rr6902a1","journal-title":"MMWR Recomm Rep"},{"issue":"21","key":"10827_CR20","doi-asserted-by":"publisher","first-page":"1","DOI":"10.2807\/ese.13.21.18879-en","volume":"13","author":"W Irving","year":"2008","unstructured":"Irving W, Salmon D, Boucher C, Hoepelman I (2008) Acute hepatitis C virus infection. EuroSurveill 13(21):1\u20134 (pii: 18879)","journal-title":"EuroSurveill"},{"issue":"3","key":"10827_CR21","doi-asserted-by":"publisher","first-page":"a037093","DOI":"10.1101\/cshperspect.a037093","volume":"10","author":"K Tabata","year":"2020","unstructured":"Tabata K, Neufeldt CJ, Bartenschlager R (2020) Hepatitis C virus replication. Cold Spring Harb Perspect Med 10(3):a037093. https:\/\/doi.org\/10.1101\/cshperspect.a037093","journal-title":"Cold Spring Harb Perspect Med"},{"key":"10827_CR22","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1007\/s00430-010-0171-0","volume":"2","author":"F Alborino","year":"2011","unstructured":"Alborino F, Burighel A, Tiller FW, van Helden J, Gabriel C, Raineri A, Catapano R, Stekel H (2011) Multicenter evaluation of a fully automated third-generation anti-HCV antibody screening test with excellent sensitivity and specificity. Med Microbiol Immunol 2:77\u201383. https:\/\/doi.org\/10.1007\/s00430-010-0171-0","journal-title":"Med Microbiol Immunol"},{"issue":"5","key":"10827_CR23","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1177\/2211068214563794","volume":"20","author":"R Mukherjee","year":"2015","unstructured":"Mukherjee R, Burns A, Rodden D, Chang F, Chaum M, Garcia N, Bollipalli N, Niemz A (2015) Diagnosis and management of hepatitis C virus infection. J Lab Autom 20(5):519\u2013538. https:\/\/doi.org\/10.1177\/2211068214563794","journal-title":"J Lab Autom"},{"issue":"19","key":"10827_CR24","doi-asserted-by":"publisher","first-page":"4257","DOI":"10.3390\/s19194257","volume":"19","author":"SD Warkad","year":"2019","unstructured":"Warkad SD, Song KS, Pal D, Nimse SB (2019) Developments in the HCV screening technologies based on the detection of antigens and antibodies. Sens (Basel) 19(19):4257. https:\/\/doi.org\/10.3390\/s19194257","journal-title":"Sens (Basel)"},{"issue":"2","key":"10827_CR25","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1016\/j.jhep.2008.11.005","volume":"50","author":"TI Michalak","year":"2009","unstructured":"Michalak TI, Pham TN (2009) Anti-HCV core antibody: a potential new marker of occult and otherwise serologically silent HCV infection. J Hepatol 50(2):244\u2013246. https:\/\/doi.org\/10.1016\/j.jhep.2008.11.005","journal-title":"J Hepatol"},{"issue":"44","key":"10827_CR26","doi-asserted-by":"publisher","first-page":"7896","DOI":"10.3748\/wjg.v19.i44.7896","volume":"19","author":"M Irshad","year":"2013","unstructured":"Irshad M, Mankotia DS, Irshad K (2013) An insight into the diagnosis and pathogenesis of hepatitis C virus infection. World J Gastroenterol 19(44):7896\u20137909. https:\/\/doi.org\/10.3748\/wjg.v19.i44.7896","journal-title":"World J Gastroenterol"},{"key":"10827_CR27","doi-asserted-by":"publisher","first-page":"1288","DOI":"10.1002\/hep.510290442","volume":"4","author":"M Beld","year":"1999","unstructured":"Beld M, Penning M, van Putten M, Lukashov V, van den Hoek A, McMorrow M, Goudsmit J (1999) Quantitative antibody responses to structural (Core) and nonstructural (NS3, NS4, and NS5) hepatitis C virus proteins among seroconverting injecting drug users: impact of epitope variation and relationship to detection of HCV RNA in blood. Hepatology 4:1288\u20131298. https:\/\/doi.org\/10.1002\/hep.510290442","journal-title":"Hepatology"},{"key":"10827_CR28","doi-asserted-by":"publisher","first-page":"1222778","DOI":"10.3389\/fcimb.2023.1222778","volume":"13","author":"H Li","year":"2023","unstructured":"Li H, Yang S, Cao D, Wang Q, Zhang S, Zhou Y, Liu D, Yang R, Cui L, Zhu Z (2023) A new double-antigen sandwich test based on the light-initiated chemiluminescent assay for detecting antihepatitis C virus antibodies with high sensitivity and specificity. Front Cell Infect Microbiol 13:1222778. https:\/\/doi.org\/10.3389\/fcimb.2023.1222778","journal-title":"Front Cell Infect Microbiol"},{"key":"10827_CR29","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1159\/000084597","volume":"48","author":"M Schroeter","year":"2005","unstructured":"Schroeter M, Zoellner B, Polywka S, Laufs R, Feucht HH (2005) Prolonged time until seroconversion among Hemodialysis patients: the need for HCV PCR. Intervirology 48:213\u2013215","journal-title":"Intervirology"},{"key":"10827_CR30","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1097\/QAD.0b013e32831940a3","volume":"23","author":"EC Thomson","year":"2009","unstructured":"Thomson EC, Nastouli E, Main J, Karayiannis P, Eliahoo J, Muir D et al (2009) Delayed anti-HCV antibody response in HIV-positive men acutely infected with HCV. AIDS 23:89\u201393","journal-title":"AIDS"},{"issue":"2","key":"10827_CR31","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1007\/s00005-013-0257-7","volume":"62","author":"J Ka\u017amierczak","year":"2014","unstructured":"Ka\u017amierczak J, Pawe\u0142czyk A, Cortes KC, Radkowski M (2014) Seronegative hepatitis C virus infection. Arch Immunol Ther Exp (Warsz) 62(2):145\u2013151. https:\/\/doi.org\/10.1007\/s00005-013-0257-7","journal-title":"Arch Immunol Ther Exp (Warsz)"},{"issue":"1","key":"10827_CR32","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1002\/jmv.24919","volume":"90","author":"SJ Shepherd","year":"2018","unstructured":"Shepherd SJ, McDonald SA, Palmateer NE, Gunson RN, Aitken C, Dore GJ, Goldberg DJ, Applegate TL, Lloyd AR, Hajarizadeh B, Grebely J, Hutchinson SJ (2018) HCV avidity as a tool for detection of recent HCV infection: sensitivity depends on HCV genotype. J Med Virol 90(1):120\u2013130. https:\/\/doi.org\/10.1002\/jmv.24919","journal-title":"J Med Virol"},{"issue":"9","key":"10827_CR33","doi-asserted-by":"publisher","first-page":"1386","DOI":"10.3390\/v16091386","volume":"16","author":"P Rzymski","year":"2024","unstructured":"Rzymski P, Brzd\u0119k M, Dobrowolska K, Poniedzia\u0142ek B, Murawska-Ochab A, Zar\u0119bska-Michaluk D, Flisiak R (2024) Like a rolling stone?? A review on spontaneous clearance of hepatitis C virus infection. Viruses 16(9):1386. https:\/\/doi.org\/10.3390\/v16091386","journal-title":"Viruses"},{"key":"10827_CR34","doi-asserted-by":"publisher","first-page":"1841","DOI":"10.1002\/jmv.25270","volume":"90","author":"M Hashem","year":"2018","unstructured":"Hashem M, Zaghla H, Zakaria Z, Allam WR, Sameea EA, Mikhail NN, Sobhy M, Galal IF, Mokhtar Y, Hamdy S et al (2018) High spontaneous clearance of symptomatic iatrogenic acute hepatitis C genotype 4 infection. J Med Virol 90:1841\u20131847. https:\/\/doi.org\/10.1002\/jmv.25270","journal-title":"J Med Virol"},{"issue":"1","key":"10827_CR35","doi-asserted-by":"publisher","first-page":"e29781","DOI":"10.1371\/journal.pone.0029781","volume":"7","author":"AS Abdel-Moneim","year":"2012","unstructured":"Abdel-Moneim AS, Bamaga MS, Shehab GM, Abu-Elsaad AA, Farahat FM (2012) HCV infection among Saudi population: high prevalence of genotype 4 and increased viral clearance rate. PLoS ONE 7(1):e29781. https:\/\/doi.org\/10.1371\/journal.pone.0029781","journal-title":"PLoS ONE"},{"key":"10827_CR36","unstructured":"Viral Hepatitis, STD, and CDC\/National Center for HIV\/AIDS, Prevention TB, Hepatitis C (2019) Atlanta, GA: US Department of Health and Human Services, CDC; https:\/\/www.cdc.gov\/hepatitis\/hcv\/index.htm"},{"key":"10827_CR37","doi-asserted-by":"publisher","first-page":"3587","DOI":"10.1007\/s00705-017-3538-3","volume":"162","author":"RAdA Pond\u00e9","year":"2017","unstructured":"Pond\u00e9 RAdA (2017) The serological markers of acute infection with hepatitis A, B, C, D, E and G viruses revisited. Arch Virol 162:3587\u20133602. https:\/\/doi.org\/10.1007\/s00705-017-3538-3","journal-title":"Arch Virol"},{"key":"10827_CR38","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1002\/jmv.1890470316","volume":"47","author":"JM Pawlotsky","year":"1995","unstructured":"Pawlotsky JM, Darthuy F, Remire J, Pellet C, Udin L, Stuyver L, Roudot-Thoraval F, Duvoux C, Douvin C, Mallat A et al (1995) Significance of anti-hepatitis C virus core IgM antibodies in patients with chronic hepatitis C. J Med Virol 47:285\u2013291","journal-title":"J Med Virol"},{"key":"10827_CR39","doi-asserted-by":"publisher","unstructured":"Dustin LB, Charles ED (2012) Primary, post-primary and non-specific Immunoglobulin M responses in HCV infection. Antivir ther. 17(7 Pt. B1449\u20131452. https:\/\/doi.org\/10.3851\/IMP2222","DOI":"10.3851\/IMP2222"},{"issue":"2","key":"10827_CR40","doi-asserted-by":"publisher","first-page":"1846","DOI":"10.3892\/etm.2017.4682","volume":"14","author":"F Kong","year":"2017","unstructured":"Kong F, Feng B, Zhang H, Rao H, Wang J, Cong X, Wei L (2017) Abnormal phenotypic features of IgM\u2009+\u2009B cell subsets in patients with chronic hepatitis C virus infection. Exp Ther Med 14(2):1846\u20131852. https:\/\/doi.org\/10.3892\/etm.2017.4682","journal-title":"Exp Ther Med"},{"key":"10827_CR41","doi-asserted-by":"publisher","first-page":"1349","DOI":"10.1016\/j.jhep.2012.07.007","volume":"57","author":"B Hajarizadeh","year":"2012","unstructured":"Hajarizadeh B, Grebely J, Dore GJ (2012) Case definitions for acute hepatitis C virus infection: A systematic review. J Hepatol 57:1349\u20131360","journal-title":"J Hepatol"},{"key":"10827_CR42","unstructured":"Centers for Disease Control and Prevention (2016) Hepatitis C, Acute: 2016 Case Definition. CDC https:\/\/wwwn.cdc.gov\/nndss\/conditions\/hepatitis-c-acute\/case-definition\/2016\/"},{"issue":"11","key":"10827_CR43","doi-asserted-by":"publisher","first-page":"1739","DOI":"10.3390\/v16111739","volume":"16","author":"M Fasano","year":"2024","unstructured":"Fasano M, Ieva F, Ciarallo M, Caccianotti B, Santantonio TA (2024) Acute hepatitis C: current status and future perspectives. Viruses 16(11):1739. https:\/\/doi.org\/10.3390\/v16111739","journal-title":"Viruses"},{"key":"10827_CR44","first-page":"207","volume":"17","author":"E Sagnelli","year":"2003","unstructured":"Sagnelli E, Coppola N, Marrocco C, Coviello G, Rossi G, Battaglia M, Sagnelli C, Messina V, Tonziello A, Scolastico C, Filippini P (2003) Diagnosis of HCV related acute hepatitis by serial determination of IgM to HCV: a preliminary observation. J Biol Regul Homeost Agents 17:207\u2013210","journal-title":"J Biol Regul Homeost Agents"},{"issue":"3","key":"10827_CR45","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1016\/j.jcv.2009.08.009","volume":"46","author":"N Coppola","year":"2009","unstructured":"Coppola N, Pisapia R, Tonziello G, Masiello A, Martini S, Pisaturo M, Messina V, Sagnelli C, Macera M, Signoriello G, Sagnelli E (2009) Improvement in the aetiological diagnosis of acute hepatitis C: a diagnostic protocol based on the anti-HCV-IgM titre and IgG avidity index. J Clin Virol 46(3):222\u2013229. https:\/\/doi.org\/10.1016\/j.jcv.2009.08.009","journal-title":"J Clin Virol"},{"issue":"7 Pt B","key":"10827_CR46","doi-asserted-by":"publisher","first-page":"1453","DOI":"10.3851\/IMP2471","volume":"17","author":"E Sagnelli","year":"2012","unstructured":"Sagnelli E, Tonziello G, Pisaturo M, Sagnelli C, Coppola N (2012) Clinical applications of antibody avidity and Immunoglobulin M testing in acute HCV infection. Antivir Ther 17(7 Pt B):1453\u20131458. https:\/\/doi.org\/10.3851\/IMP2471","journal-title":"Antivir Ther"},{"issue":"5","key":"10827_CR47","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1080\/14787210.2019.1604221","volume":"17","author":"S Chevaliez","year":"2019","unstructured":"Chevaliez S (2019) Strategies for the improvement of HCV testing and diagnosis. Expert Rev Anti Infect Ther 17(5):341\u2013347. https:\/\/doi.org\/10.1080\/14787210.2019.1604221","journal-title":"Expert Rev Anti Infect Ther"},{"key":"10827_CR48","doi-asserted-by":"publisher","unstructured":"Flores GL, Mota JC, da Silva Andrade LT, Lopes RS, Bastos FI, Villar LM (2022) Performance of HCV Antigen Testing for the Diagnosis and Monitoring of Antiviral Treatment: A Systematic Review and Meta-Analysis. Biomed Res Int. 7348755. https:\/\/doi.org\/10.1155\/2022\/7348755","DOI":"10.1155\/2022\/7348755"},{"key":"10827_CR49","doi-asserted-by":"publisher","unstructured":"Bhattacharya D, Aronsohn A, Price J, Lo Re V, Heald J, Demisashi G, Durzy E, Davis-Owino A, Tynes S, American Association for the Study of Liver Diseases\u2013Infectious Diseases Society of America HCV Guidance Panel (2023) Hepatitis C guidance 2023 update: AASLD-IDSA recommendations for testing, managing, and treating hepatitis C virus infection. Clin Infect Dis ciad319. https:\/\/doi.org\/10.1093\/cid\/ciad319","DOI":"10.1093\/cid\/ciad319"},{"issue":"2","key":"10827_CR50","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1111\/trf.17224","volume":"63","author":"K Himmelsbach","year":"2023","unstructured":"Himmelsbach K, Mueller S, Kress J, Fiedler SA, Miskey C, Ivics Z, Patek A, Chudy M (2023) Second hepatitis C virus transmission by blood components since introduction of mandatory NAT screening in Germany. Transfusion 63(2):339\u2013347. https:\/\/doi.org\/10.1111\/trf.17224","journal-title":"Transfusion"},{"issue":"11","key":"10827_CR51","doi-asserted-by":"publisher","first-page":"e0077123","DOI":"10.1128\/jcm.00771-23","volume":"61","author":"MD Pauly","year":"2023","unstructured":"Pauly MD, Weis-Torres S, Hayden TM, Ganova-Raeva LM, Kamili S (2023) Development of simple, rapid, and sensitive methods for detection of hepatitis C virus RNA from whole blood using reverse transcription loop-mediated isothermal amplification. J Clin Microbiol 61(11):e0077123. https:\/\/doi.org\/10.1128\/jcm.00771-23","journal-title":"J Clin Microbiol"},{"issue":"4","key":"10827_CR52","doi-asserted-by":"publisher","first-page":"447","DOI":"10.3343\/alm.2022.42.4.447","volume":"42","author":"Y Park","year":"2022","unstructured":"Park Y, Roh J, Kim S (2022) Performance evaluation of the Aptima assays in comparison with the Cobas 6800 assays for the detection of HIV-1, HBV, and HCV in clinical samples. Ann Lab Med 42(4):447\u2013456. https:\/\/doi.org\/10.3343\/alm.2022.42.4.447","journal-title":"Ann Lab Med"},{"issue":"7","key":"10827_CR53","doi-asserted-by":"publisher","first-page":"951","DOI":"10.1086\/428578","volume":"40","author":"AL Cox","year":"2005","unstructured":"Cox AL, Netski DM, Mosbruger T, Sherman SG, Strathdee S, Ompad D et al (2005) Prospective evaluation of community-acquired acute-phase hepatitis C virus infection. Clin Infect Dis 40(7):951\u2013958. https:\/\/doi.org\/10.1086\/428578","journal-title":"Clin Infect Dis"},{"issue":"1","key":"10827_CR54","doi-asserted-by":"publisher","first-page":"e226907","DOI":"10.1136\/bcr-2018-226907","volume":"11","author":"S Takamizawa","year":"2018","unstructured":"Takamizawa S, Yamada T, Kitamura K, Hiraoka E (2018) Difficulty of acute hepatitis C diagnosis in a hospitalised patient. BMJ Case Rep 11(1):e226907. https:\/\/doi.org\/10.1136\/bcr-2018-226907","journal-title":"BMJ Case Rep"},{"issue":"6","key":"10827_CR55","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1111\/j.1365-2893.2004.00533.x","volume":"11","author":"SN Lu","year":"2004","unstructured":"Lu SN, Tung HD, Chen TM, Lee CM, Wang JH, Hung CH, Chen CH, Changchien CS (2004) Is it possible to diagnose acute hepatitis C virus (HCV) infection by a rising anti-HCV titre rather than by seroconversion? J Viral Hepat 11(6):563\u2013570. https:\/\/doi.org\/10.1111\/j.1365-2893.2004.00533.x","journal-title":"J Viral Hepat"},{"issue":"17","key":"10827_CR56","doi-asserted-by":"publisher","first-page":"1661","DOI":"10.2174\/138161208784746789","volume":"14","author":"P Fabris","year":"2008","unstructured":"Fabris P, Fleming VM, Giordani MT, Barnes E (2008) Acute hepatitis C: clinical aspects, diagnosis, and outcome of acute HCV infection. Curr Pharm Des 14(17):1661\u20131665. https:\/\/doi.org\/10.2174\/138161208784746789","journal-title":"Curr Pharm Des"},{"issue":"1","key":"10827_CR57","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1128\/JCM.01064-10","volume":"49","author":"AC Araujo","year":"2011","unstructured":"Araujo AC, Astrakhantseva IV, Fields HA, Kamili S (2011) Distinguishing acute from chronic hepatitis C virus (HCV) infection based on antibody reactivities to specific HCV structural and nonstructural proteins. J Clin Microbiol 49(1):54\u201357. https:\/\/doi.org\/10.1128\/JCM.01064-10","journal-title":"J Clin Microbiol"},{"issue":"6","key":"10827_CR58","doi-asserted-by":"publisher","first-page":"1177","DOI":"10.1016\/j.jhep.2012.07.031","volume":"57","author":"P Mahale","year":"2012","unstructured":"Mahale P, Kontoyiannis DP, Chemaly RF, Jiang Y, Hwang JP, Davila M, Torres HA (2012) Acute exacerbation and reactivation of chronic hepatitis C virus infection in cancer patients. J Hepatol 57(6):1177\u20131185. https:\/\/doi.org\/10.1016\/j.jhep.2012.07.031","journal-title":"J Hepatol"},{"issue":"1","key":"10827_CR59","doi-asserted-by":"publisher","first-page":"183","DOI":"10.3390\/v15010183","volume":"15","author":"T Kanda","year":"2023","unstructured":"Kanda T, Matsumoto N, Ishii T, Arima S, Shibuya S, Honda M, Sasaki-Tanaka R, Masuzaki R, Kanezawa S, Nishizawa T, Gon Y, Ogawa M, Kogure H (2023) Chronic hepatitis C: acute exacerbation and Alanine aminotransferase flare. Viruses 15(1):183. https:\/\/doi.org\/10.3390\/v15010183","journal-title":"Viruses"},{"issue":"9","key":"10827_CR60","doi-asserted-by":"publisher","first-page":"873","DOI":"10.1111\/jvh.13302","volume":"27","author":"YR Li","year":"2020","unstructured":"Li YR, Chen WC, Tsai WL, Cheng JS, Tsay FW, Kao SS, Chen HC, Hsu PI (2020) Severe acute exacerbation of HCV infection in cancer patients who undergo chemotherapy without antiviral prophylaxis. J Viral Hepat 27(9):873\u2013879. https:\/\/doi.org\/10.1111\/jvh.13302","journal-title":"J Viral Hepat"},{"key":"10827_CR61","doi-asserted-by":"publisher","first-page":"1174","DOI":"10.1016\/j.cgh.2013.03.025","volume":"11","author":"E Sagnelli","year":"2013","unstructured":"Sagnelli E, Pisaturo M, Stanzione M, Messina V, Alessio L, Sagnelli C, Starace M, Pasquale G, Coppola N (2013) Clinical presentation, outcome, and response to therapy among patients with acute exacerbation of chronic hepatitis C. Clin Gastroenterol Hepatol 11:1174\u20131180e11. https:\/\/doi.org\/10.1016\/j.cgh.2013.03.025","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"22","key":"10827_CR62","doi-asserted-by":"publisher","first-page":"6707","DOI":"10.3748\/wjg.v20.i22.6707","volume":"20","author":"E Sagnelli","year":"2014","unstructured":"Sagnelli E, Sagnelli C, Pisaturo M, Coppola N (2014) Hepatic flares in chronic hepatitis C: spontaneous exacerbation vs hepatotropic viruses superinfection. World J Gastroenterol 20(22):6707\u20136715. https:\/\/doi.org\/10.3748\/wjg.v20.i22.6707","journal-title":"World J Gastroenterol"},{"key":"10827_CR63","doi-asserted-by":"publisher","first-page":"1051","DOI":"10.1086\/605561","volume":"49","author":"BH McGovern","year":"2009","unstructured":"McGovern BH, Birch CE, Bowen MJ, Reyor LL, Nagami EH, Chung RT et al (2009) Improving the diagnosis of acute hepatitis C virus infection with expanded viral load criteria. Clin Infect Dis 49:1051\u20131060","journal-title":"Clin Infect Dis"},{"key":"10827_CR64","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1136\/gut.2004.048009","volume":"54","author":"MG Rumi","year":"2005","unstructured":"Rumi MG, De Filippi F, La Vecchia C, Donato MF, Gallus S, Del Ninno E, Colombo M (2005) Hepatitis C reactivation in patients with chronic infection with genotypes 1b and 2c: a retrospective cohort study of 206 untreated patients. Gut 54:402\u2013406. https:\/\/doi.org\/10.1136\/gut.2004.048009","journal-title":"Gut"},{"key":"10827_CR65","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1002\/jmv.20263","volume":"75","author":"N Hiraga","year":"2005","unstructured":"Hiraga N, Suzuki F, Akuta N, Suzuki Y, Sezaki H, Hosaka T, Someya T, Kobayashi M, Saitoh S, Arase Y et al (2005) Clinical and virological characteristics of untreated patients with chronic hepatitis C who develop serum Alanine aminotransferase flare-up. J Med Virol 75:240\u2013248","journal-title":"J Med Virol"},{"issue":"4","key":"10827_CR66","doi-asserted-by":"publisher","first-page":"313","DOI":"10.3960\/jslrt.24042","volume":"64","author":"Y Motomura","year":"2024","unstructured":"Motomura Y, Yoshifuji K, Tanaka K, Sakashita C, Umezawa Y, Nagao T, Nitta S, Asahina Y, Mori T, Yamamoto M (2024) Hepatitis C virus-related hepatitis flare after immunochemotherapy in a patient with follicular lymphoma. J Clin Exp Hematop 64(4):313\u2013317. https:\/\/doi.org\/10.3960\/jslrt.24042","journal-title":"J Clin Exp Hematop"},{"issue":"1","key":"10827_CR67","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1002\/hep.29344","volume":"67","author":"HA Torres","year":"2018","unstructured":"Torres HA, Hosry J, Mahale P, Economides MP, Jiang Y, Lok AS (2018) Hepatitis C virus reactivation in patients receiving cancer treatment: A prospective observational study. Hepatology 67(1):36\u201347. https:\/\/doi.org\/10.1002\/hep.29344","journal-title":"Hepatology"},{"issue":"10","key":"10827_CR68","doi-asserted-by":"publisher","first-page":"1321","DOI":"10.1016\/j.cmi.2022.02.042","volume":"28","author":"K Mustafayev","year":"2022","unstructured":"Mustafayev K, Torres H (2022) Hepatitis B virus and hepatitis C virus reactivation in cancer patients receiving novel anticancer therapies. Clin Microbiol Infect 28(10):1321\u20131327. https:\/\/doi.org\/10.1016\/j.cmi.2022.02.042","journal-title":"Clin Microbiol Infect"},{"key":"10827_CR69","doi-asserted-by":"publisher","first-page":"121","DOI":"10.2147\/IMCRJ.S444521","volume":"17","author":"J Cheng","year":"2024","unstructured":"Cheng J, Pan J, Zhao D, Ma X, Sun Q, Li J (2024) HCV reactivation in a patient with hepatocellular carcinoma due to sorafenib: A case report. Int Med Case Rep J 17:121\u2013124. https:\/\/doi.org\/10.2147\/IMCRJ.S444521","journal-title":"Int Med Case Rep J"},{"key":"10827_CR70","doi-asserted-by":"publisher","first-page":"1136111","DOI":"10.3389\/fmed.2023.1136111","volume":"10","author":"YT Su","year":"2023","unstructured":"Su YT, Chang ML, Liaw YF (2023) Case report: unusual viral evolutions following antiviral therapies in a patient with concurrent hepatitis B virus and hepatitis C virus infection. Front Med (Lausanne) 10:1136111. https:\/\/doi.org\/10.3389\/fmed.2023.1136111","journal-title":"Front Med (Lausanne)"},{"issue":"22","key":"10827_CR71","doi-asserted-by":"publisher","first-page":"6716","DOI":"10.3748\/wjg.v20.i22.6716","volume":"20","author":"O Yazici","year":"2014","unstructured":"Yazici O, Sendur MA, Aksoy S (2014) Hepatitis C virus reactivation in cancer patients in the era of targeted therapies. World J Gastroenterol 20(22):6716\u20136724. https:\/\/doi.org\/10.3748\/wjg.v20.i22.6716","journal-title":"World J Gastroenterol"},{"key":"10827_CR72","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/j.msard.2016.08.003","volume":"9","author":"A Tagawa","year":"2016","unstructured":"Tagawa A, Ogawa T, Tetsuka S, Otsuka M, Hashimoto R, Kato H, Ando K, Tanabe H (2016) Hepatitis C virus (HCV) reactivation during Fingolimod treatment for relapsing and remitting multiple sclerosis. Mult Scler Relat Disord 9:155\u2013157. https:\/\/doi.org\/10.1016\/j.msard.2016.08.003","journal-title":"Mult Scler Relat Disord"},{"issue":"3","key":"10827_CR73","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1007\/s12328-024-01944-9","volume":"17","author":"H Kaneko","year":"2024","unstructured":"Kaneko H, Ozono Y, Iwakiri H, Hatada H, Uchiyama N, Komaki Y, Nakamura K, Hasuike S, Nagata K, Kawakami H (2024) Reactivation of hepatitis C virus caused by steroid monotherapy for sudden deafness. Clin J Gastroenterol 17(3):505\u2013510. https:\/\/doi.org\/10.1007\/s12328-024-01944-9","journal-title":"Clin J Gastroenterol"},{"key":"10827_CR74","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1016\/j.jhin.2007.12.008","volume":"68","author":"K Cardell","year":"2008","unstructured":"Cardell K, Widell A, Fryd\u00e9n A, Akerling B, Mansson A, Franz\u00e9n S, Lymer U, Isaksson B (2008) Nosocomial hepatitis C in thoracic surgery unit; retrospective findings generating a prospective study. J Hosp Infect 68:322\u2013328","journal-title":"J Hosp Infect"},{"issue":"5","key":"10827_CR75","doi-asserted-by":"publisher","first-page":"2083","DOI":"10.1016\/j.transproceed.2005.03.045","volume":"37","author":"S Melon","year":"2005","unstructured":"Melon S, Galarraga M, Villar M, Laures A, Boga J, de O\u00f1a M, Gomez E (2005) Hepatitis C v\u00edrus reactivation in anti-hepatitic C virus-positive renal transplant recipients. Transpl Proc 37(5):2083\u20132085","journal-title":"Transpl Proc"},{"issue":"4","key":"10827_CR76","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1016\/j.jhep.2011.06.031","volume":"56","author":"DN Samonakis","year":"2012","unstructured":"Samonakis DN, Germani G, Burroughs AK (2012) Immunosuppression and HCV recurrence after liver transplantation. J Hepatol 56(4):973\u2013983. https:\/\/doi.org\/10.1016\/j.jhep.2011.06.031","journal-title":"J Hepatol"},{"issue":"6","key":"10827_CR77","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1046\/j.1440-1746.2001.02502.x","volume":"16","author":"J Chen","year":"2001","unstructured":"Chen J, Chung J, Kao J, Chen D (2001) Post-partum acute exacerbation of chronic hepatitis in a hepatitis C-carrier mother. J Gastroenterol Hepatol 16(6):705\u2013708","journal-title":"J Gastroenterol Hepatol"},{"issue":"4","key":"10827_CR78","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1016\/j.trim.2004.10.001","volume":"13","author":"AR Zekri","year":"2004","unstructured":"Zekri AR, Mohamed WS, Samra MA, Sherif GM, El-Shehaby AM, El-Sayed MH (2004) Risk factors for cytomegalovirus, hepatitis B and C virus reactivation after bone marrow transplantation. Transpl Immunol 13(4):305\u2013311. https:\/\/doi.org\/10.1016\/j.trim.2004.10.001","journal-title":"Transpl Immunol"},{"key":"10827_CR79","doi-asserted-by":"publisher","first-page":"1422","DOI":"10.1002\/lt.21266","volume":"13","author":"A Humar","year":"2007","unstructured":"Humar A, Washburn K, Freeman R, Paya C, Mouas H, Alecock E, Razonable R (2007) An assessment of interactions between hepatitis C virus and herpesvirus reactivation in liver transplant recipients using molecular surveillance. Liver Transpl 13:1422\u20131427","journal-title":"Liver Transpl"},{"issue":"3","key":"10827_CR80","doi-asserted-by":"publisher","first-page":"e347","DOI":"10.1097\/TXD.0000000000000763","volume":"4","author":"RA Mitchell","year":"2028","unstructured":"Mitchell RA, Hussaini T, Yau AH, Krajden M, Wright AJ, Scudamore CH, Marquez Azalgara V, Erb SR, Yoshida EM (2028) Transplantation of a liver allograft from a hepatitis C virus seropositive donor with previous sustained virologic response to an uninfected recipient suffering steroid refractory acute graft rejection with no evidence of HCV transmission. Transpl Direct 4(3):e347. https:\/\/doi.org\/10.1097\/TXD.0000000000000763","journal-title":"Transpl Direct"},{"issue":"9","key":"10827_CR81","doi-asserted-by":"publisher","first-page":"1858","DOI":"10.3390\/v14091858","volume":"14","author":"YT Su","year":"2022","unstructured":"Su YT, Chang ML, Chien RN, Liaw YF (2022) Hepatitis C virus reactivation in Anti-HCV Antibody-Positive patients with chronic hepatitis B following Anti-HBV therapies. Viruses 14(9):1858. https:\/\/doi.org\/10.3390\/v14091858","journal-title":"Viruses"},{"issue":"3","key":"10827_CR82","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1038\/nrclinonc.2012.1","volume":"9","author":"HA Torres","year":"2012","unstructured":"Torres HA, Davila M (2012) Reactivation of hepatitis B virus and hepatitis C virus in patients with cancer. Nat Rev Clin Oncol 9(3):156\u2013166. https:\/\/doi.org\/10.1038\/nrclinonc.2012.1","journal-title":"Nat Rev Clin Oncol"},{"key":"10827_CR83","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1016\/S0168-8278(96)80136-X","volume":"24","author":"IS Sheen","year":"1996","unstructured":"Sheen IS, Liaw YF, Lin DY, Chu CM (1996) Acute exacerbations in chronic hepatitis C: a clinico pathological and prognostic study. J Hepatol 24:525\u2013531","journal-title":"J Hepatol"},{"key":"10827_CR84","doi-asserted-by":"publisher","unstructured":"Gane EJ (2008) The natural history of recurrent hepatitis C and what influences this. Liver Transpl 14 Suppl 2S36\u201344. https:\/\/doi.org\/10.1002\/lt.21646","DOI":"10.1002\/lt.21646"},{"key":"10827_CR85","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1016\/S2468-1253(21)00472-6","volume":"7","author":"HCV Polaris Observatory","year":"2022","unstructured":"Polaris Observatory HCV, Collaborators (2022) Global change in hepatitis C virus prevalence and cascade of care between 2015 and 2020: a modelling study. Lancet Gastroenterol Hepatol 7:396\u2013415","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"10827_CR86","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1111\/j.1365-2893.2005.00651.x","volume":"13","author":"JM Micallef","year":"2006","unstructured":"Micallef JM, Kaldor JM, Dore GJ (2006) Spontaneous viral clearance following acute hepatitis C infection: a systematic review of longitudinal studies. J Viral Hepat 13:34\u201341","journal-title":"J Viral Hepat"},{"key":"10827_CR87","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1002\/hep.26639","volume":"59","author":"J Grebely","year":"2014","unstructured":"Grebely J, Page K, Sacks-Davis R, van der Loeff MS, Rice TM, Bruneau J, InC3 Study Group et al (2014) The effects of female sex, viral genotype, and IL28B genotype on spontaneous clearance of acute hepatitis C virus infection. Hepatology 59:109\u2013120","journal-title":"Hepatology"},{"issue":"4","key":"10827_CR88","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1007\/s11606-017-4280-y","volume":"33","author":"D Guss","year":"2018","unstructured":"Guss D, Sherigar J, Rosen P, Mohanty SR (2018) Diagnosis and management of hepatitis C infection in primary care settings. J Gen Intern Med 33(4):551\u2013557. https:\/\/doi.org\/10.1007\/s11606-017-4280-y","journal-title":"J Gen Intern Med"},{"issue":"4","key":"10827_CR89","doi-asserted-by":"publisher","first-page":"305","DOI":"10.3390\/cells8040305","volume":"8","author":"D Lapa","year":"2019","unstructured":"Lapa D, Garbuglia AR, Capobianchi MR, Del Porto P (2019) Hepatitis C virus genetic variability, human immune response, and genome polymorphisms: which is the interplay?? Cells 8(4):305. https:\/\/doi.org\/10.3390\/cells8040305","journal-title":"Cells"},{"issue":"6","key":"10827_CR90","doi-asserted-by":"publisher","first-page":"2140","DOI":"10.1002\/hep.27013","volume":"59","author":"WO Osburn","year":"2014","unstructured":"Osburn WO, Snider AE, Wells BL et al (2014) Clearance of hepatitis C infection is associated with the early appearance of broad neutralizing antibody responses. Hepatology 59(6):2140\u20132151. https:\/\/doi.org\/10.1002\/hep.27013","journal-title":"Hepatology"},{"issue":"4","key":"10827_CR91","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1016\/j.immuni.2017.09.006","volume":"47","author":"D Wolski","year":"2017","unstructured":"Wolski D, Foote PK, Chen DY et al (2017) Transcriptional divergence marks Virus-Specific primary human CD8+ T cells in chronic versus acute infection. Immunity 47(4):648\u2013663e8. https:\/\/doi.org\/10.1016\/j.immuni.2017.09.006","journal-title":"Immunity"},{"key":"10827_CR92","doi-asserted-by":"publisher","unstructured":"Kinchen VJ, Zahid MN, Flyak AI et al (2018) Broadly Neutralizing Antibody Mediated Clearance of Human Hepatitis C Virus Infection. Cell Host Microbe. 2018;24(5):717\u2013730.e5. https:\/\/doi.org\/10.1016\/j.chom.2018.10.012","DOI":"10.1016\/j.chom.2018.10.012"},{"issue":"11","key":"10827_CR93","doi-asserted-by":"publisher","first-page":"4786","DOI":"10.1172\/JCI130720","volume":"129","author":"VJ Kinchen","year":"2019","unstructured":"Kinchen VJ, Massaccesi G, Flyak AI et al (2019) Plasma Deconvolution identifies broadly neutralizing antibodies associated with hepatitis C virus clearance. J Clin Invest 129(11):4786\u20134796. https:\/\/doi.org\/10.1172\/JCI130720","journal-title":"J Clin Invest"},{"issue":"2","key":"10827_CR94","doi-asserted-by":"publisher","first-page":"e1000313","DOI":"10.1371\/journal.ppat.1000313","volume":"5","author":"N Nakamoto","year":"2009","unstructured":"Nakamoto N, Cho H, Shaked A et al (2009) Synergistic reversal of intrahepatic HCV-specific CD8 T cell exhaustion by combined PD-1\/CTLA-4 Blockade. PLoS Pathog 5(2):e1000313. https:\/\/doi.org\/10.1371\/journal.ppat.1000313","journal-title":"PLoS Pathog"},{"issue":"11","key":"10827_CR95","doi-asserted-by":"publisher","first-page":"1387","DOI":"10.3109\/00365521.2016.1170875","volume":"51","author":"HJ Hartling","year":"2016","unstructured":"Hartling HJ, Ballegaard VC, Nielsen NS, Gaardbo JC, Nielsen SD (2016) Immune regulation in chronic hepatitis C virus infection. Scand J Gastroenterol 51(11):1387\u20131397. https:\/\/doi.org\/10.3109\/00365521.2016.1170875","journal-title":"Scand J Gastroenterol"},{"issue":"5","key":"10827_CR96","doi-asserted-by":"publisher","first-page":"2909","DOI":"10.3892\/mmr.2017.6351","volume":"15","author":"Z Yan","year":"2017","unstructured":"Yan Z, Wang Y (2017) Viral and host factors associated with outcomes of hepatitis C virus infection (Review). Mol Med Rep 15(5):2909\u20132924. https:\/\/doi.org\/10.3892\/mmr.2017.6351","journal-title":"Mol Med Rep"},{"key":"10827_CR97","doi-asserted-by":"publisher","unstructured":"Loomba R, Rivera MM, McBurney R, Park Y, Haynes-Williams V, Rehermann B, Alter HJ, Herrine SK, Liang TJ, Hoofnagle JH, Heller T (2011) The natural history of acute hepatitis C: clinical presentation, laboratory findings and treatment outcomes. Aliment Pharmacol Ther. 2011;33(5):559\u2013\u200965. https:\/\/doi.org\/10.1111\/j.1365-2036.2010.04549.x","DOI":"10.1111\/j.1365-2036.2010.04549.x"},{"issue":"1 Suppl","key":"10827_CR98","doi-asserted-by":"publisher","first-page":"S58","DOI":"10.1016\/j.jhep.2014.07.012","volume":"61","author":"RH Westbrook","year":"2014","unstructured":"Westbrook RH, Dusheiko G (2014) Natural history of hepatitis C. J Hepatol 61(1 Suppl):S58\u201368. https:\/\/doi.org\/10.1016\/j.jhep.2014.07.012","journal-title":"J Hepatol"},{"issue":"10","key":"10827_CR99","doi-asserted-by":"publisher","first-page":"1249","DOI":"10.3390\/cells8101249","volume":"8","author":"M Khatun","year":"2019","unstructured":"Khatun M, Ray RB (2019) Mechanisms underlying hepatitis C Virus-Associated hepatic fibrosis. Cells 8(10):1249. https:\/\/doi.org\/10.3390\/cells8101249","journal-title":"Cells"},{"issue":"5","key":"10827_CR100","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1016\/S1665-2681(19)31439-5","volume":"11","author":"MV Reggiardo","year":"2012","unstructured":"Reggiardo MV, Fay F, Tanno M, Garc\u00eda-Camacho G, Bottaso O, Ferretti S, Godoy A, Guerrita C, Paez M, Tanno F, Ruffinengo O, Benetti S, Garc\u00eda Borr\u00e1s SE, Rossi MC, Vorobioff J, Bessone F, Tanno H (2012) Natural history of hepatitis C virus infection in a cohort of asymptomatic post-transfused subjects. Ann Hepatol 11(5):658\u2013666","journal-title":"Ann Hepatol"},{"key":"10827_CR101","doi-asserted-by":"publisher","first-page":"17006","DOI":"10.1038\/nrdp.2017.6","volume":"3","author":"MP Manns","year":"2017","unstructured":"Manns MP, Buti M, Gane E, Pawlotsky JM, Razavi H, Terrault N, Younossi Z (2017) Hepatitis C virus infection. Nat Rev Dis Primers 3:17006. https:\/\/doi.org\/10.1038\/nrdp.2017.6","journal-title":"Nat Rev Dis Primers"},{"issue":"12","key":"10827_CR102","doi-asserted-by":"publisher","first-page":"866","DOI":"10.1056\/NEJM199909163411202","volume":"341","author":"M Vogt","year":"1999","unstructured":"Vogt M, Lang T, Frosner G, Klingler C, Sendl A, Zeller A et al (1999) Prevalence and clinical outcome of hepatitis C infection in children who underwent cardiac surgery before the implementation of blood-donor screening. N Engl J Med 341(12):866\u2013870","journal-title":"N Engl J Med"},{"key":"10827_CR103","doi-asserted-by":"publisher","unstructured":"Cho YK, Kim YN, Song BC (2015) Predictors of spontaneous viral clearance and outcomes of acute hepatitis C infection. Clin Mol Hepatol. 20(4):368\u2013\u200975. doi: 10.3350\/cmh.2014.20.4.368. Epub 2014 Dec 24. Erratum in: Clin Mol Hepatol. 2015;21(1):104. https:\/\/doi.org\/10.3350\/cmh.2015.21.1.104","DOI":"10.3350\/cmh.2015.21.1.104"},{"key":"10827_CR104","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1016\/j.cgh.2019.04.035","volume":"18","author":"S Seo","year":"2020","unstructured":"Seo S, Silverberg MJ, Hurley LB et al (2020) Prevalence of spontaneous clearance of hepatitis C virus infection doubled from 1998 to 2017. Clin Gastroenterol Hepatol 18:511\u2013513","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"6","key":"10827_CR105","doi-asserted-by":"publisher","first-page":"896","DOI":"10.1111\/liv.12362","volume":"34","author":"M Cubero","year":"2014","unstructured":"Cubero M, Gregori J, Esteban JI, Garc\u00eda-Cehic D, Bes M, Perales C, Domingo E, Rodr\u00edguez-Fr\u00edas F, Sauleda S, Casillas R, Sanchez A, Ortega I, Esteban R, Guardia J, Quer J (2014) Identification of host and viral factors involved in a dissimilar resolution of a hepatitis C virus infection. Liver Int 34(6):896\u2013906. https:\/\/doi.org\/10.1111\/liv.12362","journal-title":"Liver Int"},{"key":"10827_CR106","doi-asserted-by":"publisher","first-page":"S43","DOI":"10.1093\/cid\/cis368","volume":"55","author":"S Kamili","year":"2012","unstructured":"Kamili S, Drobeniuc J, Araujo AC, Hayden TM (2012) Laboratory diagnostics for hepatitis C virus infection. Clin Infect Dis 55:S43\u2013S48","journal-title":"Clin Infect Dis"},{"key":"10827_CR107","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1016\/j.gtc.2015.07.003","volume":"44","author":"S Lingala","year":"2015","unstructured":"Lingala S, Ghany MG (2015) Natural history of hepatitis C. Gastroenterol Clin North Am 44:717\u2013734. https:\/\/doi.org\/10.1016\/j.gtc.2015.07.003","journal-title":"Gastroenterol Clin North Am"},{"key":"10827_CR108","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1007\/s00705-016-3049-7","volume":"162","author":"GF Helaly","year":"2017","unstructured":"Helaly GF, Elsheredy AG, El Basset Mousa AA et al (2017) Seronegative and occult hepatitis C virus infections in patients with hematological disorders. Arch Virol 162:63\u201369","journal-title":"Arch Virol"},{"key":"10827_CR109","doi-asserted-by":"publisher","first-page":"445","DOI":"10.4103\/ijmr.IJMR","volume":"147","author":"A Kumar","year":"2018","unstructured":"Kumar A, Rajput M, Paliwal D, Yadav A, Chhabra R, Singh S (2018) Genotyping & diagnostic methods for hepatitis C virus: A need of low-resource countries. Indian J Med Res 147:445. https:\/\/doi.org\/10.4103\/ijmr.IJMR","journal-title":"Indian J Med Res"},{"issue":"2","key":"10827_CR110","doi-asserted-by":"publisher","first-page":"125","DOI":"10.5114\/ceh.2022.115116","volume":"8","author":"ZM Saad","year":"2022","unstructured":"Saad ZM, Ghany WAE, Khalifa R, Higazi A, Al-Shazly M, Said M, Keryakos H (2022) Occult HCV infection in liver transplanted patients: frequency and consequences. Clin Exp Hepatol 8(2):125\u2013131. https:\/\/doi.org\/10.5114\/ceh.2022.115116","journal-title":"Clin Exp Hepatol"},{"key":"10827_CR111","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1186\/1471-2334-11-15","volume":"11","author":"AM Strasak","year":"2011","unstructured":"Strasak AM, Kim AY, Lauer GM, de Sousa PS, Ginuino CF, Fernandes CA, Velloso CE, de Almeida AJ, de Oliveira JM, Yoshida CF et al (2011) Antibody dynamics and spontaneous viral clearance in patients with acute hepatitis C infection in Rio de janeiro, Brazil. BMC Infect Dis 11:15","journal-title":"BMC Infect Dis"},{"key":"10827_CR112","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1093\/infdis\/jir835","volume":"205","author":"S Raghuraman","year":"2012","unstructured":"Raghuraman S, Park H, Osburn WO, Winkelstein E, Edlin BR, Rehermann B (2012) Spontaneous clearance of chronic hepatitis C virus infection is associated with appearance of neutralizing antibodies and reversal of T-cell exhaustion. J Infect Dis 205:763\u2013771","journal-title":"J Infect Dis"},{"issue":"1","key":"10827_CR113","doi-asserted-by":"publisher","first-page":"5446","DOI":"10.1038\/s41467-022-33035-z","volume":"13","author":"A Nishio","year":"2022","unstructured":"Nishio A, Hasan S, Park H, Park N, Salas JH, Salinas E, Kardava L, Juneau P, Frumento N, Massaccesi G, Moir S, Bailey JR, Grakoui A, Ghany MG, Rehermann B (2022) Serum neutralization activity declines but memory B cells persist after cure of chronic hepatitis C. Nat Commun 13(1):5446. https:\/\/doi.org\/10.1038\/s41467-022-33035-z","journal-title":"Nat Commun"},{"issue":"13","key":"10827_CR114","doi-asserted-by":"publisher","first-page":"3418","DOI":"10.3748\/wjg.v20.i13.3418","volume":"20","author":"JR Larrubia","year":"2014","unstructured":"Larrubia JR, Moreno-Cubero E, Lokhande MU, Garc\u00eda-Garz\u00f3n S, L\u00e1zaro A, Miquel J, Perna C, Sanz-de-Villalobos E (2014) Adaptive immune response during hepatitis C virus infection. World J Gastroenterol 20(13):3418\u20133430. https:\/\/doi.org\/10.3748\/wjg.v20.i13.3418","journal-title":"World J Gastroenterol"},{"key":"10827_CR115","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.coviro.2020.10.002","volume":"46","author":"JD Stuart","year":"2021","unstructured":"Stuart JD, Salinas E, Grakoui A (2021) Immune system control of hepatitis C virus infection. Curr Opin Virol 46:36\u201344. https:\/\/doi.org\/10.1016\/j.coviro.2020.10.002","journal-title":"Curr Opin Virol"},{"issue":"7","key":"10827_CR116","doi-asserted-by":"publisher","first-page":"826","DOI":"10.2174\/1389450116666150825110532","volume":"18","author":"LB Dustin","year":"2017","unstructured":"Dustin LB (2017) Innate and adaptive immune responses in chronic HCV infection. Curr Drug Targets 18(7):826\u2013843. https:\/\/doi.org\/10.2174\/1389450116666150825110532","journal-title":"Curr Drug Targets"},{"issue":"16","key":"10827_CR117","doi-asserted-by":"publisher","first-page":"5644","DOI":"10.3390\/ijms21165644","volume":"21","author":"J Kemming","year":"2020","unstructured":"Kemming J, Thimme R, Neumann-Haefelin C (2020) Adaptive immune response against hepatitis C virus. Int J Mol Sci 21(16):5644. https:\/\/doi.org\/10.3390\/ijms21165644","journal-title":"Int J Mol Sci"},{"key":"10827_CR118","doi-asserted-by":"publisher","first-page":"19450","DOI":"10.1073\/pnas.0809879105","volume":"105","author":"M Gal-Tanamy","year":"2008","unstructured":"Gal-Tanamy M, Keck ZY, Yi M, McKeating JA, Patel AH, Foung SK, Lemon SM (2008) In vitro selection of a neutralization-resistant hepatitis C virus escape mutant. Proc Natl Acad Sci USA 105:19450\u201319455","journal-title":"Proc Natl Acad Sci USA"},{"key":"10827_CR119","doi-asserted-by":"crossref","unstructured":"Logvino_C, Major ME, Oldach D, Heyward S, Talal A, Balfe P, Feinstone SM, Alter H, Rice CM, McKeating JA (2004) Neutralizing antibody response during acute and chronic hepatitis C virus infection. Proc Natl Acad Sci USA 101:10149\u201310154","DOI":"10.1073\/pnas.0403519101"},{"key":"10827_CR120","doi-asserted-by":"publisher","first-page":"1391","DOI":"10.3390\/v14071391","volume":"14","author":"VM Cowton","year":"2022","unstructured":"Cowton VM, Dunlop JI, Cole SJ, Swann RE, Patel AH (2022) The neutralizing antibody responses of individuals that spontaneously resolve hepatitis C virus infection. Viruses 14:1391. https:\/\/doi.org\/10.3390\/v14071391","journal-title":"Viruses"},{"issue":"3","key":"10827_CR121","doi-asserted-by":"publisher","first-page":"101626","DOI":"10.1016\/j.clinre.2021.101626","volume":"45","author":"S Roger","year":"2021","unstructured":"Roger S, Ducancelle A, Le Guillou-Guillemette H, Gaudy C, Lunel F (2021) HCV virology and diagnosis. Clin Res Hepatol Gastroenterol 45(3):101626. https:\/\/doi.org\/10.1016\/j.clinre.2021.101626","journal-title":"Clin Res Hepatol Gastroenterol"},{"key":"10827_CR122","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.coviro.2021.07.003","volume":"50","author":"N Frumento","year":"2021","unstructured":"Frumento N, Flyak AI, Bailey JR (2021) Mechanisms of HCV resistance to broadly neutralizing antibodies. Curr Opin Virol 50:23\u201329. https:\/\/doi.org\/10.1016\/j.coviro.2021.07.003","journal-title":"Curr Opin Virol"},{"key":"10827_CR123","doi-asserted-by":"publisher","first-page":"1730","DOI":"10.1086\/429834","volume":"191","author":"M Radkowski","year":"2005","unstructured":"Radkowski M, Horban A, Gallegos-Orozco JF et al (2005) Evidence for viral persistence in patients who test positive for antihepatitis C virus antibodies and have normal Alanine aminotransferase levels. J Infect Dis 191:1730\u20131733","journal-title":"J Infect Dis"},{"issue":"9","key":"10827_CR124","doi-asserted-by":"publisher","first-page":"2144","DOI":"10.1111\/trf.16006","volume":"60","author":"T An","year":"2020","unstructured":"An T, Dean M, Flower R, Tatzenko T, Chan HT, Kiely P, Faddy HM (2020) Understanding occult hepatitis C infection. Transfusion 60(9):2144\u20132152. https:\/\/doi.org\/10.1111\/trf.16006","journal-title":"Transfusion"},{"key":"10827_CR125","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1016\/j.jcv.2014.09.007","volume":"61","author":"V Carre\u00f1o","year":"2014","unstructured":"Carre\u00f1o V (2014) Seronegative occult hepatitis C virus infection: clinical implications. J Clin Virol 61:315\u2013320","journal-title":"J Clin Virol"},{"key":"10827_CR126","doi-asserted-by":"publisher","first-page":"1554","DOI":"10.1002\/jmv.21866","volume":"82","author":"I Castillo","year":"2010","unstructured":"Castillo I, Bartolom\u00e9 J, Quiroga JA, et a (2010) Diagnosis of occult hepatitis C without the need for a liver biopsy. J Med Virol 82:1554\u20131559","journal-title":"J Med Virol"},{"key":"10827_CR127","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1111\/j.1365-2893.2006.00783.x","volume":"14","author":"M Pardo","year":"2007","unstructured":"Pardo M, L\u00f3pez-Alcorocho JM, Rodr\u00edguez-I\u00f1igo E et al (2007) Comparative study between occult hepatitis C virus infection and chronic hepatitis C. J Viral Hepat 14:36\u201340","journal-title":"J Viral Hepat"},{"key":"10827_CR128","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1038\/ki.2014.68","volume":"86","author":"I Castillo","year":"2014","unstructured":"Castillo I, Martinez-Ara J, Olea T et al (2014) High prevalence of occult hepatitis C virus infection in patients with primary and secondary glomerular nephropathies. Kidney Int 86:619\u2013624","journal-title":"Kidney Int"},{"key":"10827_CR129","doi-asserted-by":"publisher","first-page":"1388","DOI":"10.1002\/jmv.24467","volume":"88","author":"SS Abdelrahim","year":"2016","unstructured":"Abdelrahim SS, Khairy R, Esmail MAM et al (2016) Occult hepatitis C virus infection among Egyptian Hemodialysis patients. J Med Virol 88:1388\u20131393","journal-title":"J Med Virol"},{"issue":"2","key":"10827_CR130","doi-asserted-by":"publisher","first-page":"242","DOI":"10.4254\/wjh.v13.i2.242","volume":"13","author":"MR Hedayati-Moghaddam","year":"2021","unstructured":"Hedayati-Moghaddam MR, Soltanian H, Ahmadi-Ghezeldasht S (2021) Occult hepatitis C virus infection in the middle East and Eastern mediterranean countries: A systematic review and meta-analysis. World J Hepatol 13(2):242\u2013260. https:\/\/doi.org\/10.4254\/wjh.v13.i2.242","journal-title":"World J Hepatol"},{"key":"10827_CR131","doi-asserted-by":"publisher","first-page":"1431","DOI":"10.1002\/hep.22802","volume":"49","author":"SA Macparland","year":"2009","unstructured":"Macparland SA, Pham TNQ, Guy CS et al (2009) Hepatitis C virus persisting after clinically apparent sustained virological response to antiviral therapy retains infectivity in vitro. Hepatology 49:1431\u20131441","journal-title":"Hepatology"},{"issue":"3","key":"10827_CR132","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1111\/j.1537-2995.2004.00656.x","volume":"44","author":"JJ Lefr\u00e8re","year":"2004","unstructured":"Lefr\u00e8re JJ, Girot R, Lefr\u00e8re F, Guillaume N, Lerable J, Le Marrec N, Bouchardeau F, Laperche S (2004) Complete or partial seroreversion in immunocompetent individuals after self-limited HCV infection: consequences for transfusion. Transfusion 44(3):343\u2013348. https:\/\/doi.org\/10.1111\/j.1537-2995.2004.00656.x","journal-title":"Transfusion"},{"issue":"2","key":"10827_CR133","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1111\/1744-9987.13535","volume":"25","author":"S Mahmoudvand","year":"2021","unstructured":"Mahmoudvand S, Shokri S, Azaran A, Seyedian SS, Makvandi M, Mirzaei H, Sheikhrobat SB (2021) Seronegative occult hepatitis C infection among Hemodialysis patients: A prevalence study. Ther Apher Dial 25(2):218\u2013224. https:\/\/doi.org\/10.1111\/1744-9987.13535","journal-title":"Ther Apher Dial"},{"issue":"5","key":"10827_CR134","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1089\/apc.2022.0021","volume":"36","author":"J O\u2019Shea","year":"2022","unstructured":"O\u2019Shea J, Oliver N, Cartwright EJ (2022) Diagnosis and clinical manifestations of acute hepatitis C infection in people living with HIV. AIDS Patient Care STDS 36(5):172\u2013177. https:\/\/doi.org\/10.1089\/apc.2022.0021","journal-title":"AIDS Patient Care STDS"},{"issue":"3","key":"10827_CR135","doi-asserted-by":"publisher","first-page":"179","DOI":"10.5662\/wjm.v12.i3.179","volume":"12","author":"DS Mbaga","year":"2022","unstructured":"Mbaga DS, Kenmoe S, Biko\u00ef JN, Takuissu GR, Amougou-Atsama M, Okobalemba EA, Ebogo-Belobo JT, Bowo-Ngandji A, Oyono MG, Magoudjou-Pekam JN, Kame-Ngasse GI, Nka AD, Feudjio AF, Zemnou-Tepap C, Velhima EA, Ondigui JLN, Nayang-Mundo RA, Touangnou-Chamda SA, Takeu YK, Taya-Fokou JB, Mikangue CAM, Kenfack-Momo R, Kengne-Nd\u00e9 C, Sake CS, Esemu SN, Njouom R, Ndip L, Essama SHR (2022) Global prevalence of occult hepatitis C virus: A systematic review and meta-analysis. World J Methodol 12(3):179\u2013190. https:\/\/doi.org\/10.5662\/wjm.v12.i3.179","journal-title":"World J Methodol"},{"issue":"10","key":"10827_CR136","doi-asserted-by":"publisher","first-page":"2703","DOI":"10.1007\/s00705-021-05126-7","volume":"166","author":"S Nasimzadeh","year":"2021","unstructured":"Nasimzadeh S, Azaran A, Jalilian S, Makvandi M, Seyedian SS, Keikhaei B, Mehr FJ (2021) Prevalence of occult hepatitis C virus infection in beta-thalassemia major patients in Ahvaz. Iran Arch Virol 166(10):2703\u20132710. https:\/\/doi.org\/10.1007\/s00705-021-05126-7","journal-title":"Iran Arch Virol"},{"issue":"5","key":"10827_CR137","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1111\/j.1478-3231.2004.0947.x","volume":"24","author":"RT Marinho","year":"2004","unstructured":"Marinho RT, Pinto RM, Santos ML, de Moura MC (2004) Lymphocyte T helper-specific reactivity in sustained responders to interferon and ribavirin with negativation (seroreversion) of anti-hepatitis C virus. Liver Int 24(5):413\u2013418. https:\/\/doi.org\/10.1111\/j.1478-3231.2004.0947.x","journal-title":"Liver Int"},{"issue":"5","key":"10827_CR138","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1136\/gut.50.5.693","volume":"50","author":"LA Kondili","year":"2002","unstructured":"Kondili LA, Chionne P, Costantino A, Villano U, Lo Noce C, Pannozzo F, Mele A, Giampaoli S, Rapicetta M (2002) Infection rate and spontaneous seroreversion of anti-hepatitis C virus during the natural course of hepatitis C virus infection in the general population. Gut 50(5):693\u2013696. https:\/\/doi.org\/10.1136\/gut.50.5.693","journal-title":"Gut"},{"key":"10827_CR139","doi-asserted-by":"publisher","first-page":"2887","DOI":"10.3748\/wjg.v18.i23.2887","volume":"18","author":"V Carreno","year":"2012","unstructured":"Carreno V, Bartolome J, Castillo I, Quiroga JA (2012) New perspectives in occult hepatitis C virus infection. World J Gastroenterol 18:2887\u20132894","journal-title":"World J Gastroenterol"},{"issue":"1","key":"10827_CR140","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1007\/s00705-016-3049-7","volume":"162","author":"GF Helaly","year":"2021","unstructured":"Helaly GF, Elsheredy AG, El Basset Mousa AA, Ahmed HKF, Oluyemi AES (2021) Seronegative and occult hepatitis C virus infections in patients with hematological disorders. Arch Virol 162(1):63\u201369. https:\/\/doi.org\/10.1007\/s00705-016-3049-7","journal-title":"Arch Virol"},{"key":"10827_CR141","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1093\/infdis\/175.2.316","volume":"175","author":"JJ Lefr\u00e8re","year":"1997","unstructured":"Lefr\u00e8re JJ, Guiramand S, Lefr\u00e8re F et al (1997) Full or partial seroreversion in patients infected by hepatitis C virus. J Infect Dis 175:316\u2013322","journal-title":"J Infect Dis"},{"issue":"2","key":"10827_CR142","doi-asserted-by":"publisher","first-page":"30","DOI":"10.21315\/mjms2024.31.2.4","volume":"31","author":"SNF Abdul Rahman","year":"2024","unstructured":"Abdul Rahman SNF, Hamzah HA, Mustafa Mahmud MIA, Mat Harun N (2024) Molecular analysis and ex vivo infectivity of seronegative occult hepatitis C virus: A study in single haemodialysis centre. Malays J Med Sci 31(2):30\u201342. https:\/\/doi.org\/10.21315\/mjms2024.31.2.4","journal-title":"Malays J Med Sci"},{"issue":"2","key":"10827_CR143","doi-asserted-by":"publisher","first-page":"228","DOI":"10.3748\/wjg.v7.i2.228","volume":"7","author":"V Meier","year":"2001","unstructured":"Meier V, Mihm S, Braun Wietzke P, Ramadori G (2001) HCV-RNA positivity in peripheral blood mononuclear cells of patients with chronic HCV infection: does it really mean viral replication? World J Gastroenterol 7(2):228\u2013234","journal-title":"World J Gastroenterol"},{"issue":"2","key":"10827_CR144","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1016\/j.virol.2007.04.003","volume":"365","author":"F Bernardin","year":"2007","unstructured":"Bernardin F, Stramer SL, Rehermann B, Page-Shafer K, Cooper S, Bangsberg DR, Hahn J, Tobler L, Busch M, Delwart E (2007) High levels of subgenomic HCV plasma RNA in Immunosilent infections. Virology 365(2):446\u2013456. https:\/\/doi.org\/10.1016\/j.virol.2007.04.003","journal-title":"Virology"},{"issue":"2","key":"10827_CR145","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1111\/trf.13381","volume":"56","author":"MT Vo","year":"2016","unstructured":"Vo MT, Bruhn R, Kaidarova Z, Custer BS, Murphy EL, Bloch EM (2016) A retrospective analysis of false-positive infectious screening results in blood donors. Transfusion 56(2):457\u2013465. https:\/\/doi.org\/10.1111\/trf.13381","journal-title":"Transfusion"},{"key":"10827_CR146","doi-asserted-by":"crossref","unstructured":"Candotti, D., Sauvage, V., Cappy, P., Boullahi, M. A., Bizimana, P.,\u2026 Mbensa, G.O. (2019). High rate of hepatitis C virus and human immunodeficiency virus false-positive results in serologic screening in sub\u2010Saharan Africa: adverse impact on the blood supply. Transfusion. doi:10.1111\/trf.15593","DOI":"10.1111\/trf.15593"},{"key":"10827_CR147","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jcv.2017.01.007","volume":"89","author":"AC Moorman","year":"2017","unstructured":"Moorman AC, Drobenuic J, Kamili S (2017) Prevalence of false-positive hepatitis C antibody results, National health and nutrition examination study (NHANES) 2007\u20132012. J Clin Virol 89:1\u20134. https:\/\/doi.org\/10.1016\/j.jcv.2017.01.007","journal-title":"J Clin Virol"},{"issue":"1","key":"10827_CR148","doi-asserted-by":"publisher","first-page":"8689","DOI":"10.1038\/s41598-021-88138-2","volume":"11","author":"Y Huang","year":"2021","unstructured":"Huang Y, Pan H, Gao Q, Lv P, Xu X, Zhao Z (2021) The role of a two-assay serological testing strategy for anti-HCV screening in low-prevalence populations. Sci Rep 11(1):8689. https:\/\/doi.org\/10.1038\/s41598-021-88138-2","journal-title":"Sci Rep"},{"issue":"1","key":"10827_CR149","doi-asserted-by":"publisher","first-page":"e22165","DOI":"10.1002\/jcla.22165","volume":"32","author":"B Kim","year":"2018","unstructured":"Kim B, Ahn HJ, Choi MH, Park Y (2018) Retrospective analysis on the diagnostic performances and signal-to-cut-off ratios of the Elecsys Anti-HCV II assay. J Clin Lab Anal 32(1):e22165. https:\/\/doi.org\/10.1002\/jcla.22165","journal-title":"J Clin Lab Anal"},{"issue":"7","key":"10827_CR150","doi-asserted-by":"publisher","first-page":"e0235036","DOI":"10.1371\/journal.pone.0235036","volume":"15","author":"G Jargalsaikhan","year":"2020","unstructured":"Jargalsaikhan G, Eichner M, Boldbaatar D, Bat-Ulzii P, Lkhagva-Ochir O, Oidovsambuu O, Dashtseren B, Namjil E, Genden Z, Yagaanbuyant D, Tuya A, Gurjav N, Mordorj A, Bungert A, Dashdorj N, Dashdorj N (2020) Sensitivity and specificity of commercially available rapid diagnostic tests for viral hepatitis B and C screening in serum samples. PLoS ONE 15(7):e0235036. https:\/\/doi.org\/10.1371\/journal.pone.0235036","journal-title":"PLoS ONE"},{"key":"10827_CR151","doi-asserted-by":"publisher","first-page":"105293","DOI":"10.1016\/j.jcv.2022.105293","volume":"156","author":"M Majchrzak","year":"2022","unstructured":"Majchrzak M, Bronner K, Laperche S, Riester E, Bakker E, Bollhagen R, Klinkicht M, Vermeulen M, Schmidt M (2022) Multicenter performance evaluation of the Elecsys HCV duo immunoassay. J Clin Virol 156:105293. https:\/\/doi.org\/10.1016\/j.jcv.2022.105293","journal-title":"J Clin Virol"},{"issue":"1","key":"10827_CR152","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1007\/s12288-018-0968-3","volume":"35","author":"M Wadood","year":"2019","unstructured":"Wadood M, Usman M (2019) Comparative analysis of electrochemiluminescence assay and chemiluminescent microparticle immunoassay for the screening of hepatitis C. Indian J Hematol Blood Transfus 35(1):131\u2013136. https:\/\/doi.org\/10.1007\/s12288-018-0968-3","journal-title":"Indian J Hematol Blood Transfus"},{"issue":"2","key":"10827_CR153","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1111\/tme.12930","volume":"33","author":"AS Nishiya","year":"2023","unstructured":"Nishiya AS, de Almeida-Neto C, Witkin SS, Ferreira SC, Salles NA, Nogueira FAH, Oliveira CDL, Rocha V, Mendrone J\u00fanior A (2023) Improved detection of hepatitis C virus-positive blood donors and determination of infection status. Transfus Med 33(2):159\u2013164. https:\/\/doi.org\/10.1111\/tme.12930","journal-title":"Transfus Med"},{"key":"10827_CR154","doi-asserted-by":"publisher","first-page":"1420","DOI":"10.1177\/147323000903700516","volume":"37","author":"R Kesli","year":"2009","unstructured":"Kesli R, Ozdemir M, Kurtoglu MG, Baykan M, Baysal B (2009) Evaluation and comparison of three different anti hepatitis C virus antibody test based on chemiluminescence and Enzyme-Linked immunosorbent assay methods used in the diagnosis of hepatitis C infections in Turkey. J Int Med Res 37:1420\u20131429. https:\/\/doi.org\/10.1177\/147323000903700516","journal-title":"J Int Med Res"},{"issue":"3","key":"10827_CR155","doi-asserted-by":"publisher","first-page":"362","DOI":"10.3904\/kjim.2022.350","volume":"38","author":"JG Kang","year":"2023","unstructured":"Kang JG, Jang MK, Kim JH, Jung JH, Park JW, Kim SE, Park SH, Lee MS, Suk KT, Kim DJ, Kim HS (2023) The diagnostic significance of hepatitis C virus antibody levels for chronic hepatitis C virus infection. Korean J Intern Med 38(3):362\u2013371. https:\/\/doi.org\/10.3904\/kjim.2022.350","journal-title":"Korean J Intern Med"},{"issue":"3","key":"10827_CR156","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1093\/labmed\/lmaa074","volume":"52","author":"MH Kim","year":"2021","unstructured":"Kim MH, Kang SY, Lee WI, Lee MY (2021) Evaluation of HCV RNA by PCR and Signal-to-Cutoff ratios of HCV antibody assays for diagnosis of HCV infection. Lab Med 52(3):240\u2013244. https:\/\/doi.org\/10.1093\/labmed\/lmaa074","journal-title":"Lab Med"},{"issue":"3","key":"10827_CR157","doi-asserted-by":"publisher","first-page":"522","DOI":"10.3855\/jidc.13750","volume":"16","author":"A Hussin","year":"2022","unstructured":"Hussin A, Yusof R, Nor Rahim MY, Dalusim F, Othman NI, Ibrahim N, Shahidan MA (2022) True-positive reflex threshold value for HCV antibody screening test. J Infect Dev Ctries 16(3):522\u2013527. https:\/\/doi.org\/10.3855\/jidc.13750","journal-title":"J Infect Dev Ctries"},{"key":"10827_CR158","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1046\/j.1537-2995.2003.00304.x","volume":"43","author":"CR Seed","year":"2003","unstructured":"Seed CR, Margaritis AR, Bolton WV et al (2003) Improved efficiency of National HIV, HCV, and HTLV antibody testing algorithms based on sequential screening immunoassays. Transfusion 43:226\u2013234","journal-title":"Transfusion"},{"issue":"5","key":"10827_CR159","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1111\/tme.12152","volume":"24","author":"K Zhang","year":"2014","unstructured":"Zhang K, Wang L, Sun Y, Zhang R, Lin G, Xie J, Li J (2014) Improving the safety of blood transfusion by using a combination of two screening assays for hepatitis C virus. Transfus Med 24(5):297\u2013304. https:\/\/doi.org\/10.1111\/tme.12152","journal-title":"Transfus Med"},{"issue":"1","key":"10827_CR160","doi-asserted-by":"publisher","first-page":"25","DOI":"10.4097\/kja.21209","volume":"75","author":"FS Nahm","year":"2022","unstructured":"Nahm FS (2022) Receiver operating characteristic curve: overview and practical use for clinicians. Korean J Anesthesiol 75(1):25\u201336. https:\/\/doi.org\/10.4097\/kja.21209","journal-title":"Korean J Anesthesiol"},{"key":"10827_CR161","unstructured":"Alter MJ, Kuhnert WL, L (2003) Finelli, centers for disease, prevention, guidelines for laboratory testing and result reporting of antibody to hepatitis C virus. centers for disease control and prevention. MMWR Recomm Rep 52;1\u201313 15; quiz CE11-14."},{"issue":"8","key":"10827_CR162","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1007\/s10096-013-1857-1","volume":"32","author":"RA Pond\u00e9","year":"2013","unstructured":"Pond\u00e9 RA (2013) Enzyme-linked immunosorbent\/chemiluminescence assays, Recombinant Immunoblot assays and nucleic acid tests in the diagnosis of HCV infection. Eur J Clin Microbiol Infect Dis 32(8):985\u2013988. https:\/\/doi.org\/10.1007\/s10096-013-1857-1","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10827_CR163","first-page":"362","volume":"62","author":"Centers for Disease Control and Prevention","year":"2013","unstructured":"Centers for Disease Control and Prevention (2013) Testing for HCV infection: an update of guidance for clinicians and laboratorians. MMWR Morb Mortal Wkly Rep 62:362\u2013365","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10827_CR164","first-page":"362","volume":"62","author":"JP Getchell","year":"2013","unstructured":"Getchell JP, Wroblewski KE, DeMaria A Jr, Bean CL, Parker MM, Pandori M, Dufour DR, Busch MP, Meyer WA, Pesano RL, Teo C-G, Beckett GA, Araujo AC, Branson BM, Drobeniuc J, Hatia R, Holmberg SD, Kamili S, Ward JW (2013) Testing for HCV infection: an update of guidance for clinicians and laboratorians. MMWR Morb Mortal Wkly Rep 62:362\u2013365","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"3","key":"10827_CR165","doi-asserted-by":"publisher","first-page":"e01567","DOI":"10.1128\/JCM.01567-18","volume":"57","author":"M Kodani","year":"2019","unstructured":"Kodani M, Martin M, de Castro VL, Drobeniuc J, Kamili S (2019) An automated Immunoblot method for detection of IgG antibodies to hepatitis C virus: a potential supplemental antibody confirmatory assay. J Clin Microbiol 57(3):e01567\u2013e01518. https:\/\/doi.org\/10.1128\/JCM.01567-18","journal-title":"J Clin Microbiol"},{"issue":"5","key":"10827_CR166","doi-asserted-by":"publisher","first-page":"466","DOI":"10.3343\/alm.2018.38.5.466","volume":"38","author":"MS Choi","year":"2018","unstructured":"Choi MS, Lee K, Hong YJ, Song EY, Kim DS, Song J (2018) The role of the Signal-to-Cutoff ratio in automated Anti-HCV chemiluminescent immunoassays by referring to the nucleic acid amplification test and the Recombinant Immunoblot assay. Ann Lab Med 38(5):466\u2013472. https:\/\/doi.org\/10.3343\/alm.2018.38.5.466","journal-title":"Ann Lab Med"},{"issue":"3","key":"10827_CR167","doi-asserted-by":"publisher","first-page":"505","DOI":"10.3390\/v14030505","volume":"14","author":"L Di Marco","year":"2022","unstructured":"Di Marco L, La Mantia C, Di Marco V (2022) Hepatitis C: standard of treatment and what to do for global elimination. Viruses 14(3):505. https:\/\/doi.org\/10.3390\/v14030505","journal-title":"Viruses"}],"container-title":["Molecular Biology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-025-10827-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11033-025-10827-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-025-10827-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,28]],"date-time":"2025-12-28T04:26:18Z","timestamp":1766895978000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11033-025-10827-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,17]]},"references-count":167,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["10827"],"URL":"https:\/\/doi.org\/10.1007\/s11033-025-10827-2","relation":{},"ISSN":["0301-4851","1573-4978"],"issn-type":[{"value":"0301-4851","type":"print"},{"value":"1573-4978","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,17]]},"assertion":[{"value":"30 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 July 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"\u201cThe authors declare that they have no conflict of interest.\u201d","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"\u2018Not applicable\u2019 for that section.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"\u2018Not applicable\u2019 for that section.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"\u2018Not applicable\u2019 for that section.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"The author declares that no generative artificial intelligence (AI) or AI-assisted technologies were used in the writing process of this manuscript.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declaration of generative AI in scientific writing"}},{"value":"The author declares that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper. The author further states that this paper comprises a review article that, for its compilation, it did not require research involving human participants and\/or animals.","order":7,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest\/competing interests"}}],"article-number":"730"}}